de Maistre E - Search Results

1

A chromogenic assay allows reliable measurement of factor VIII levels in the presence of strong lupus anticoagulants.

de Maistre E, Wahl D, Perret-Guillaume C, Regnault V, Clarac S, Briquel ME, Andre E, Lecompte T. de Maistre E, et al. Thromb Haemost. 1998 Jan;79(1):237-8. Thromb Haemost. 1998. PMID: 9459356 No abstract available.

2

[Role of the hemostasis laboratory in the etiologic approach to deep vein thrombosis].

De Maistre E, Briquel ME, Andre E, Regnault V, Whal D, Perret C, Laprevote MC, Lecompte T. De Maistre E, et al. J Mal Vasc. 1996;21(1):1-6. J Mal Vasc. 1996. PMID: 8656085 Review. French.

3

Comparative assessment of phospholipid-binding antibodies indicates limited overlapping.

de Maistre E, Gobert B, Béné MC, Briquel ME, Lecompte T, Faure GC. de Maistre E, et al. J Clin Lab Anal. 1996;10(1):6-12. doi: 10.1002/(SICI)1098-2825(1996)10:1<6::AID-JCLA2>3.0.CO;2-C. J Clin Lab Anal. 1996. PMID: 8926568

4

[Antiplatelet agents (inhibitors of platelet function) orally administered. Bases for their practical use in coronary artery disease].

Lecompte T, de Maistre E. Lecompte T, et al. Among authors: de maistre e. Arch Mal Coeur Vaiss. 1996 Nov;89(11 Suppl):1507-13. Arch Mal Coeur Vaiss. 1996. PMID: 9092411 Review. French.

5

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.

Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G. Wahl DG, et al. Among authors: de maistre e. Lupus. 1997;6(5):467-73. doi: 10.1177/096120339700600510. Lupus. 1997. PMID: 9229367

6

Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis.

Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Wahl DG, et al. Among authors: de maistre e. Lupus. 1998;7(1):15-22. doi: 10.1191/096120398678919688. Lupus. 1998. PMID: 9493144

7

Antibodies against phospholipids and beta 2-glycoprotein I increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus.

Wahl DG, De Maistre E, Guillemin F, Regnault V, Perret-Guillaume C, Lecompte T. Wahl DG, et al. Among authors: de maistre e. QJM. 1998 Feb;91(2):125-30. doi: 10.1093/qjmed/91.2.125. QJM. 1998. PMID: 9578894

8

[Heparin-induced thrombopenias: new treatments].

Lecompte T, de Maistre E, Wahl D. Lecompte T, et al. Among authors: de maistre e. Rev Med Interne. 1998 Nov;19(11):783-6. doi: 10.1016/s0248-8663(98)80381-0. Rev Med Interne. 1998. PMID: 9864775 Review. French. No abstract available.

9

Heparin-induced thrombocytopenia in France, 1980-1998.

Nguyen P, de Maistre E, Cornillet-Lefebvre P, Regnault V, Lecompte T. Nguyen P, et al. Among authors: de maistre e. Semin Thromb Hemost. 1999;25 Suppl 1:9-15. Semin Thromb Hemost. 1999. PMID: 10357146

10

An unexpected factor VIII inhibitor in a patient with Sweet's syndrome being treated with corticosteroids.

Granel F, Barbraud A, Schmutz JL, De Maistre E, Lecompte T. Granel F, et al. Among authors: de maistre e. Am J Med. 2000 Apr 1;108(5):434-5. doi: 10.1016/s0002-9343(99)00252-1. Am J Med. 2000. PMID: 10759106 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters